Diagnos Inc (DGNOF)

$0.29 +0.02 (6.04%)
Market Cap 33.44M
Revenue (ttm) 50,000.00
Net Income (ttm) -3.30M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -6,600.00%
Debt to Equity Ratio 1.76
Volume 133,900
Avg Vol 106,988
Day's Range N/A - N/A
Shares Out 121.04M
Stochastic %K 85%
Beta -0.10
Analysts Strong Buy
Price Target N/A

Company Profile

DIAGNOS Inc. provides software-based services for healthcare sector in Canada, the United States, Mexico, and internationally. It offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy, as well as allows eye care specialists to visualize normal retinal landmarks and pathological changes. The company also provides various consulting services in the fields of data analysis and a...

Industry: Health Information Services
Sector: Healthcare
Phone: 450 678 8882
Address:
7005 Taschereau Boulevard, Suite 265, Brossard, Canada
Emerging_Growth_Research
Emerging_Growth_Research Jun. 9 at 9:16 PM
$DGNOF @EmergingGrowth1 Emerging Growth Research releases a flash report on DIAGNOS $DGNOF. To read the full version of the flash report go here: https://emerginggrowth.com/wp-content/uploads/2026/06/DIAGNOS-Inc.-DGNOF-Flash-Report-6.3.2026.pdf Emerging Growth Research noted that DIAGNOS is positioned to benefit from several favorable long-term trends, including the aging global population, increasing prevalence of diabetes-related eye disease, shortages of eye-care specialists, and growing adoption of artificial intelligence in healthcare diagnostics.
0 · Reply
Latest News on DGNOF
No data available.
Emerging_Growth_Research
Emerging_Growth_Research Jun. 9 at 9:16 PM
$DGNOF @EmergingGrowth1 Emerging Growth Research releases a flash report on DIAGNOS $DGNOF. To read the full version of the flash report go here: https://emerginggrowth.com/wp-content/uploads/2026/06/DIAGNOS-Inc.-DGNOF-Flash-Report-6.3.2026.pdf Emerging Growth Research noted that DIAGNOS is positioned to benefit from several favorable long-term trends, including the aging global population, increasing prevalence of diabetes-related eye disease, shortages of eye-care specialists, and growing adoption of artificial intelligence in healthcare diagnostics.
0 · Reply